Principal Investigator
Gina D'Amato
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230466
Clinical Trial Summary
A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator's Choice for the Treatment of Patients with Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy
Phase
Phase II/III
Funding Agency/Sponsor
National Cooperative Group
Disease
Bone and Soft Tissue Cancers
Contact Information
Phone Number
305-243-2647